Chia‐Jui Yen

12.2k total citations
139 papers, 1.8k citations indexed

About

Chia‐Jui Yen is a scholar working on Oncology, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chia‐Jui Yen has authored 139 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Oncology, 43 papers in Hepatology and 35 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chia‐Jui Yen's work include Hepatocellular Carcinoma Treatment and Prognosis (36 papers), Pancreatic and Hepatic Oncology Research (26 papers) and Cancer Immunotherapy and Biomarkers (25 papers). Chia‐Jui Yen is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (36 papers), Pancreatic and Hepatic Oncology Research (26 papers) and Cancer Immunotherapy and Biomarkers (25 papers). Chia‐Jui Yen collaborates with scholars based in Taiwan, United States and South Korea. Chia‐Jui Yen's co-authors include Yan‐Shen Shan, Ih‐Jen Su, Hung‐Wen Tsai, Ann‐Lii Cheng, Chih‐Jung Wang, Wenya Huang, Chiun Hsu, Yoon‐Koo Kang, Andrew X. Zhu and Yee Chao and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Hepatology.

In The Last Decade

Chia‐Jui Yen

133 papers receiving 1.8k citations

Peers

Chia‐Jui Yen

HEPAT

ONCOL

PRM

EPIDE

Tianqiang Song China

Philipp K. Haber Germany

Masahiro Takita Japan

Ik Joo Chung South Korea

Delia D’Avola Spain

Shinichi Ohkawa Japan

Oleksiy Tsybrovskyy Austria

Atsushi Nanashima Japan

Adriana Romiti Italy

Ірина Давиденко United States

Tianqiang Song China

Chia‐Jui Yen

1.1k ×1.6

HEPAT

624 ×0.9

ONCOL

549 ×1.0

347 ×0.8

PRM

561 ×1.5

EPIDE

Citations per year, relative to Chia‐Jui Yen Chia‐Jui Yen (= 1×) peers Tianqiang Song

Countries citing papers authored by Chia‐Jui Yen

Since Specialization

Citations

This map shows the geographic impact of Chia‐Jui Yen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chia‐Jui Yen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chia‐Jui Yen more than expected).

Fields of papers citing papers by Chia‐Jui Yen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chia‐Jui Yen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chia‐Jui Yen. The network helps show where Chia‐Jui Yen may publish in the future.

Co-authorship network of co-authors of Chia‐Jui Yen

This figure shows the co-authorship network connecting the top 25 collaborators of Chia‐Jui Yen. A scholar is included among the top collaborators of Chia‐Jui Yen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chia‐Jui Yen. Chia‐Jui Yen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jien, Shih‐Hao, Budiman Minasny, Bin Yang, et al.. (2025). Enhancing Soil Carbon Storage: Developing high-resolution maps of topsoil organic carbon sequestration potential in Taiwan. Geoderma. 459. 117369–117369. 2 indexed citations

Pan, Wei, Divinah Manoharan, Po‐Ya Chang, et al.. (2025). Enhanced Catalytic Cycle of Glucose Oxidation and Reactive Species with ROS and RHS Generation Mediated by Galvanic Engineering of Dual Atomic Sites on Covalent Organic Frameworks Demonstrating Synergistic Bimetal Tumor Treatment. Advanced Science. 12(29). e00515–e00515. 1 indexed citations

Yen, Chia‐Jui, et al.. (2025). Circulating tumor DNA methylation markers for the early diagnosis of hepatocellular carcinoma. Clinical and Experimental Medicine. 25(1). 83–83.

Yen, Chia‐Jui, M-H. Chen, J.-S. Chen, et al.. (2024). 1145MO CVM-005: Phase IIa study of CVM-1118, a novel oral anti-vasculogenic mimicry (VM) agent, in advanced neuroendocrine tumors (NET) after progression on prior therapy. Annals of Oncology. 35. S751–S751. 1 indexed citations

Chiang, Nai‐Jung, Chung‐Ping Hsu, Jin‐Shing Chen, et al.. (2024). MO50-3 TCOG T3221 study: the registry of genetic alterations of Taiwan biliary tract cancer. Annals of Oncology. 35. S1355–S1355. 1 indexed citations

Shitara, Kohei, Yung‐Jue Bang, Lucjan Wyrwicz, et al.. (2024). Neoadjuvant/adjuvant pembrolizumab (pembro) + chemotherapy (chemo) vs placebo (pbo) + chemo for gastric/gastroesophageal junction (G/GEJ) adenocarcinoma: Major pathologic response (mPR) in KEYNOTE-585.. Journal of Clinical Oncology. 42(16_suppl). 4073–4073. 2 indexed citations

Yen, Chia‐Jui, et al.. (2023). EZH2-mediated epigenetic silencing of tumor-suppressive let-7c/miR-99a cluster by hepatitis B virus X antigen enhances hepatocellular carcinoma progression and metastasis. Cancer Cell International. 23(1). 199–199. 9 indexed citations

Su, Yung‐Yeh, Nai‐Jung Chiang, Yi‐Hsin Yang, et al.. (2023). Real-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic Cancer. Cancers. 15(4). 1008–1008. 5 indexed citations

Shieh, Jiunn‐Min, Ting‐Wei Chang, Chia‐Jui Yen, et al.. (2023). RNA‐binding protein‐regulated fibronectin is essential for EGFR‐activated metastasis of head and neck squamous cell carcinoma. The FASEB Journal. 37(10). e23206–e23206. 2 indexed citations

10.

Tsai, Kuen‐Jer, Po‐Hsien Huang, Chia‐Jui Yen, et al.. (2023). HLA‐E^high/HLA‐G^high/HLA‐II^low Human iPSC‐Derived Cardiomyocytes Exhibit Low Immunogenicity for Heart Regeneration. Advanced Healthcare Materials. 12(29). e2301186–e2301186. 7 indexed citations

11.

Yang, Yi‐Hsin, Hsiu‐Ying Ku, Huang‐Ming Hu, et al.. (2023). The impact of preoperative waiting time in Stage II–III gastric or gastroesophageal junction cancer: A population‐based cohort study. Cancer Medicine. 12(16). 16906–16917. 3 indexed citations

12.

Zhu, Andrew X., Farshid Dayyani, Chia‐Jui Yen, et al.. (2022). Alpha-Fetoprotein as a Potential Surrogate Biomarker for Atezolizumab + Bevacizumab Treatment of Hepatocellular Carcinoma. Clinical Cancer Research. 28(16). 3537–3545. 75 indexed citations

13.

Tsai, Hung‐Wen, et al.. (2021). Predict Early Recurrence of Resectable Hepatocellular Carcinoma Using Multi-Dimensional Artificial Intelligence Analysis of Liver Fibrosis. Cancers. 13(21). 5323–5323. 7 indexed citations

14.

Chan, Anthony T.�C., M-J. Ahn, Wan Qin Chong, et al.. (2021). 163P Health-related quality of life (HRQoL) with pembrolizumab (pembro) vs chemotherapy (chemo) in platinum-pretreated recurrent or metastatic (R/M) nasopharyngeal cancer (NPC): Phase III KEYNOTE-122 study. Annals of Oncology. 32. S1452–S1452. 1 indexed citations

15.

Ducreux, Michel, Ghassan K. Abou‐Alfa, Zhenggang Ren, et al.. (2021). O-1 Results from a global phase 2 study of tislelizumab, an investigational PD-1 antibody, in patients with unresectable hepatocellular carcinoma. Annals of Oncology. 32. S217–S217. 25 indexed citations

16.

Hsiao, Jenn‐Ren, Chan‐Chi Chang, Wei‐Ting Lee, et al.. (2020). Investigating the health disparities in the association between lifestyle behaviors and the risk of head and neck cancer. Cancer Science. 111(8). 2974–2986. 8 indexed citations

17.

Chang, Chan‐Chi, Wei‐Ting Lee, Jenn‐Ren Hsiao, et al.. (2019). Oral hygiene and the overall survival of head and neck cancer patients. Cancer Medicine. 8(4). 1854–1864. 31 indexed citations

18.

Hsiao, Jenn‐Ren, Wei‐Ting Lee, Chan‐Chi Chang, et al.. (2019). Validation of Alcohol Flushing Questionnaire to Identify ALDH2 Status in a Case–Control Study of Head and Neck Cancer. Alcoholism Clinical and Experimental Research. 43(6). 1225–1233. 7 indexed citations

19.

Wu, Shan‐Ying, Sheng‐Hui Lan, Xi‐Zhang Lin, et al.. (2016). Autophagy Regulates Human Hepatocellular Carcinoma Tumorigenesis through Selective Degradation of Cyclin D1. 3(10). 2 indexed citations

20.

Lim, Ho Yeong, Jeong Heo, Hye Jin Choi, et al.. (2014). A Phase II Study of the Efficacy and Safety of the Combination Therapy of the MEK Inhibitor Refametinib (BAY 86-9766) Plus Sorafenib for Asian Patients with Unresectable Hepatocellular Carcinoma. Clinical Cancer Research. 20(23). 5976–5985. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact